These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 23646442

  • 1. [Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].
    Aksamit D, Janda K, Kuźniewski M, Krzanowski M, Ignacak E, Betkowska-Prokop A, Chowaniec E, Sułowicz W.
    Przegl Lek; 2012; 69(11):1175-9. PubMed ID: 23646442
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the interdependence between homocystein and folic acid levels in patients after kidney transplantation during a 2 year observation period].
    Janda K, Aksamit D, Krzanowski M, Kuzniewski M, Sułowicz W.
    Przegl Lek; 2013; 70(4):175-9. PubMed ID: 23991553
    [Abstract] [Full Text] [Related]

  • 3. [Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)].
    Janda K, Aksamit D, Drozdz M, Krzanowski M, Ignacak E, Kowalczyk-Michałek M, Tabor-Ciepiela B, Sułowicz W.
    Przegl Lek; 2012; 69(9):670-4. PubMed ID: 23401987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Maintenance Immunosuppression Scheme Influences Early C4d Urinary Excretion in Kidney Graft Recipients but Does Not Affect the Long-term Graft Survival.
    Zwiech R.
    Am J Ther; 2016 May; 23(3):e778-84. PubMed ID: 24777031
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.
    Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y, Ersoy A, Ocakoglu G, Yildiz A, Oruc A, Soyak H, Calapkulu M, Sahin AB, Topal NB, Okeer E, Coskun B, Kaygisiz O, Kordan Y, Vuruskan H.
    Transplant Proc; 2017 Mar 27; 49(2):270-277. PubMed ID: 28219583
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec 27; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 27; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 15. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J, First MR, OPTIMA Study Group.
    Transplantation; 2008 Jul 15; 86(1):88-95. PubMed ID: 18622283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A, Budde K, Clavien PA, Becker T, Kessler M, Pisarski P, Fornara P, Burmeister D, Hené RJ, Cassuto-Viguier E, SENIOR Study Team.
    Transplantation; 2009 Nov 15; 88(9):1101-8. PubMed ID: 19898206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.